120 related articles for article (PubMed ID: 27122390)
21. The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(-) cases in Japanese population.
Kuze T; Nakamura N; Hashimoto Y; Sasaki Y; Abe M
Jpn J Cancer Res; 2000 Dec; 91(12):1233-40. PubMed ID: 11123421
[TBL] [Abstract][Full Text] [Related]
22. The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.
Keane C; Tobin J; Gunawardana J; Francis S; Gifford G; Gabrielli S; Gill A; Stevenson W; Talaulikar D; Gould C; Jain S; Birch S; Hertzberg M; Gandhi MK
Eur J Haematol; 2019 Sep; 103(3):200-207. PubMed ID: 31211907
[TBL] [Abstract][Full Text] [Related]
23. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
24. EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.
Montes-Moreno S; Odqvist L; Diaz-Perez JA; Lopez AB; de Villambrosía SG; Mazorra F; Castillo ME; Lopez M; Pajares R; García JF; Mollejo M; Camacho FI; Ruiz-Marcellán C; Adrados M; Ortiz N; Franco R; Ortiz-Hidalgo C; Suarez-Gauthier A; Young KH; Piris MA
Mod Pathol; 2012 Jul; 25(7):968-82. PubMed ID: 22538516
[TBL] [Abstract][Full Text] [Related]
25. Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?
Ok CY; Ye Q; Li L; Manyam GC; Deng L; Goswami RR; Wang X; Montes-Moreno S; Visco C; Tzankov A; Dybkaer K; Zhang L; Abramson J; Sohani AR; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhang S; Parsons BM; Xu M; Møller MB; Winter JN; Piris MA; Xu-Monette ZY; Medeiros LJ; Young KH
Oncotarget; 2015 Jun; 6(16):13933-45. PubMed ID: 26101854
[TBL] [Abstract][Full Text] [Related]
26. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S
Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141
[TBL] [Abstract][Full Text] [Related]
27. Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.
Hu M; Trevino J; Yang L; Cao D; Liu X; Lai J
In Vivo; 2018; 32(2):413-417. PubMed ID: 29475930
[TBL] [Abstract][Full Text] [Related]
28. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
29. pSTAT3 and MYC in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Teoh SH; Khoo JJ; Abdul Salam DSD; Peh SC; Cheah SC
Malays J Pathol; 2019 Dec; 41(3):273-281. PubMed ID: 31901912
[TBL] [Abstract][Full Text] [Related]
30. EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.
Courville EL; Yohe S; Chou D; Nardi V; Lazaryan A; Thakral B; Nelson AC; Ferry JA; Sohani AR
Mod Pathol; 2016 Oct; 29(10):1200-11. PubMed ID: 27443517
[TBL] [Abstract][Full Text] [Related]
31. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients.
Cohen M; Narbaitz M; Metrebian F; De Matteo E; Preciado MV; Chabay PA
Int J Cancer; 2014 Dec; 135(12):2816-24. PubMed ID: 24789501
[TBL] [Abstract][Full Text] [Related]
33. Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancer.
John T; Yanagawa N; Kohler D; Craddock KJ; Bandarchi-Chamkhaleh B; Pintilie M; Sykes J; To C; Li M; Panchal D; Chen W; Shepherd FA; Tsao MS
J Thorac Oncol; 2012 Jul; 7(7):1101-8. PubMed ID: 22617243
[TBL] [Abstract][Full Text] [Related]
34. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus (EBV) provides survival factors to EBV
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
[TBL] [Abstract][Full Text] [Related]
36. B-cell posttransplant lymphoproliferative disorder isolated to the central nervous system is Epstein-Barr virus positive and lacks p53 and Myc expression by immunohistochemistry.
Sundin A; Grzywacz BJ; Yohe S; Linden MA; Courville EL
Hum Pathol; 2017 Mar; 61():140-147. PubMed ID: 27993575
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
Stuhlmann-Laeisz C; Szczepanowski M; Borchert A; Brüggemann M; Klapper W
Virchows Arch; 2015 Jan; 466(1):85-92. PubMed ID: 25339301
[TBL] [Abstract][Full Text] [Related]
38. A clinicopathological study of primary central nervous system lymphomas & their association with Epstein-Barr virus.
Sharma MC; Gupta RK; Kaushal S; Suri V; Sarkar C; Singh M; Kale SS; Sahoo RK; Kumar L; Raina V
Indian J Med Res; 2016 May; 143(5):605-15. PubMed ID: 27488004
[TBL] [Abstract][Full Text] [Related]
39. BCL2 positive and BCL6 negative diffuse large B cell lymphoma patients benefit from R-CHOP therapy irrespective of germinal and non germinal center B cell like subtypes.
Jovanovic MP; Mihaljevic B; Jakovic L; Martinovic VC; Fekete MD; Andjelic B; Antic D; Bogdanovic A; Boricic N; Terzic T; Jelicic J; Milenkovic S
J BUON; 2015; 20(3):820-8. PubMed ID: 26214636
[TBL] [Abstract][Full Text] [Related]
40. Genetic and immunohistochemical characterization of Epstein-Barr virus-associated diffuse large B-cell lymphoma.
Al-Humood S; Alqallaf A; Al-Shemmari S; Al-Faris L; Al-Ayadhy B
Acta Haematol; 2014; 131(1):1-10. PubMed ID: 24008861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]